{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:15Z","timestamp":1787026695773,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["21377720D"],"award-info":[{"award-number":["21377720D"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preeclampsia (PE) is a pregnancy complication defined by new onset hypertension and proteinuria or other maternal organ damage after 20\u2009weeks of gestation. Although non-invasive prenatal testing (NIPT) has been widely used to detect fetal chromosomal abnormalities during pregnancy, its performance in combination with maternal risk factors to screen for PE has not been extensively validated. Our aim was to develop and validate classifiers that predict early- or late-onset PE using the maternal plasma cell-free DNA (cfDNA) profile and clinical risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively collected and analyzed NIPT data of 2,727 pregnant women aged 24\u201345\u2009years from four hospitals in China, which had previously been used to screen for fetal aneuploidy at 12\u2009+\u20090\u2009~\u200922\u2009+\u20096\u2009weeks of gestation. According to the diagnostic criteria for PE and the time of diagnosis (34\u2009weeks of gestation), a total of 143 early-, 580 late-onset PE samples and 2,004 healthy controls were included. The wilcoxon rank sum test was used to identify the cfDNA profile for PE prediction. The Fisher\u2019s exact test and Mann\u2013Whitney U-test were used to compare categorical and continuous variables of clinical risk factors between PE samples and healthy controls, respectively. Machine learning methods were performed to develop and validate PE classifiers based on the cfDNA profile and clinical risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By using NIPT data to analyze cfDNA coverages in promoter regions, we found the cfDNA profile, which was differential cfDNA coverages in gene promoter regions between PE and healthy controls, could be used to predict early- and late-onset PE. Maternal age, body mass index, parity, past medical histories and method of conception were significantly differential between PE and healthy pregnant women. With a false positive rate of 10%, the classifiers based on the combination of the cfDNA profile and clinical risk factors predicted early- and late-onset PE in four datasets with an average accuracy of 89 and 80% and an average sensitivity of 63 and 48%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Incorporating cfDNA profiles in classifiers might reduce performance variations in PE models based only on clinical risk factors, potentially expanding the application of NIPT in PE screening in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1254467","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:21:18Z","timestamp":1713313278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factors"],"prefix":"10.3389","volume":"11","author":[{"given":"Yan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suihua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mob.2000.107928","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","article-title":"Early prediction of preeclampsia in pregnancy with cell-free RNA","volume":"602","author":"Moufarrej","year":"2022","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41598-022-05119-9","article-title":"Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, mi R-363 and mi R-17","volume":"12","author":"Abdelazim","year":"2022","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/antiox11081608","article-title":"Oxidative and inflammatory imbalance in placenta and kidney of sFlt1-induced early-onset preeclampsia rat model","volume":"11","author":"Santana-Garrido","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US preventive services task force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.18502\/ijrm.v17i7.4857","article-title":"The relationship between body mass index and preeclampsia: a systematic review and meta-analysis","volume":"17","author":"Motedayen","year":"2019","journal-title":"Int J Reprod Biomed"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"i 1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/uog.23645","article-title":"Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China","volume":"58","author":"Hu","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref20","first-page":"241","article-title":"Nuclear acids in human blood plasma","volume":"142","author":"Mandel","year":"1948","journal-title":"C R Seances Soc Biol Fil"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/1471-0528.16292","article-title":"Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study","volume":"128","author":"Xu","year":"2021","journal-title":"BJOG"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clinbiochem.2019.07.001","article-title":"Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications","volume":"71","author":"Yuan","year":"2019","journal-title":"Clin Biochem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1901819","DOI":"10.1002\/advs.201901819","article-title":"Whole-genome promoter profiling of plasma DNA exhibits diagnostic value for placenta-origin pregnancy complications","volume":"7","author":"Guo","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1191163","DOI":"10.3389\/fmed.2023.1191163","article-title":"Use of cell-free signals as biomarkers for early and easy prediction of preeclampsia","volume":"10","author":"Gekas","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11906-023-01291-z","article-title":"Cell-free nucleic acids for early prediction of preeclampsia","volume":"26","author":"Moufarrej","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2282100","DOI":"10.1080\/01443615.2023.2282100","article-title":"Epigenetic phenotype of plasma cell-free DNA in the prediction of early-onset preeclampsia","volume":"43","author":"He","year":"2023","journal-title":"J Obstet Gynaecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/pd.6478","article-title":"Cell-free DNA methylation-based preeclampsia prediction: a journey to improve maternal health","author":"Aerden","year":"2023","journal-title":"Prenat Diagn"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"661884","DOI":"10.3389\/fgene.2021.661884","article-title":"Clinical efficiency of non-invasive prenatal screening for common Trisomies in low-risk and twin pregnancies","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G: profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7202837","article-title":"TLR4 modulates senescence and paracrine action in placental mesenchymal stem cells via inhibiting hedgehog Signaling pathway in preeclampsia","volume":"2022","author":"Zhong","year":"2022","journal-title":"Oxidative Med Cell Longev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2019.11.002","article-title":"Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population","volume":"19","author":"Liu","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e921997","DOI":"10.12659\/MSM.921997","article-title":"Identification of differentially expressed genes and Signaling pathways in placenta tissue of early-onset and late-onset pre-eclamptic pregnancies by integrated bioinformatics analysis","volume":"26","author":"Liu","year":"2020","journal-title":"Med Sci Monit"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"965167","DOI":"10.3389\/fendo.2022.965167","article-title":"Possible roles of exercise and apelin against pregnancy complications","volume":"13","author":"Alizadeh","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jri.2017.08.006","article-title":"Autophagy regulation in preeclampsia: pros and cons","volume":"123","author":"Nakashima","year":"2017","journal-title":"J Reprod Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijoa.2010.10.004","article-title":"Haemodynamic effects of oxytocin in women with severe preeclampsia","volume":"20","author":"Langesaeter","year":"2011","journal-title":"Int J Obstet Anesth"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3892\/mmr.2017.6718","article-title":"Wnt\/beta-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsia (review)","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12891\/ceog2057.2016","article-title":"Pre-eclampsia and the vascular endothelial growth factor: a new aspect","volume":"43","author":"Liberis","year":"2016","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"9140","DOI":"10.1080\/21655979.2021.1993717","article-title":"Pathogenic mechanisms of preeclampsia with severe features implied by the plasma exosomal mirna profile","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt 5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semnephrol.2010.10.005","article-title":"Renin angiotensin signaling in normal pregnancy and preeclampsia","volume":"31","author":"Irani","year":"2011","journal-title":"Semin Nephrol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/cells10113055","article-title":"Vascular dysfunction in preeclampsia","volume":"10","author":"Opichka","year":"2021","journal-title":"Cells"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.placenta.2014.12.006","article-title":"Reduced expression of the epidermal growth factor signaling system in preeclampsia","volume":"36","author":"Armant","year":"2015","journal-title":"Placenta"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12964-021-00783-2","article-title":"EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression","volume":"19","author":"Fang","year":"2021","journal-title":"Cell Commun Signal"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1254467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:21:52Z","timestamp":1713313312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1254467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":48,"alternative-id":["10.3389\/fmed.2024.1254467"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1254467","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"article-number":"1254467"}}